
### [NCIT:C95405](http://purl.obolibrary.org/obo/NCIT_C95405)
**Label:** Digestive System Neuroendocrine Carcinoma

**Subclasses:** [NCIT:C5845](http://purl.obolibrary.org/obo/NCIT_C5845) (Extrahepatic Bile Duct Small Cell Neuroendocrine Carcinoma), [NCIT:C96550](http://purl.obolibrary.org/obo/NCIT_C96550) (Anal Canal Large Cell Neuroendocrine Carcinoma), [NCIT:C60639](http://purl.obolibrary.org/obo/NCIT_C60639) (Rectal Small Cell Neuroendocrine Carcinoma), [NCIT:C96551](http://purl.obolibrary.org/obo/NCIT_C96551) (Anal Canal Small Cell Neuroendocrine Carcinoma), [NCIT:C6655](http://purl.obolibrary.org/obo/NCIT_C6655) (Ampulla of Vater Small Cell Neuroendocrine Carcinoma), [NCIT:C137862](http://purl.obolibrary.org/obo/NCIT_C137862) (Refractory Pancreatic Neuroendocrine Carcinoma), [NCIT:C96156](http://purl.obolibrary.org/obo/NCIT_C96156) (Colorectal Neuroendocrine Carcinoma), [NCIT:C96157](http://purl.obolibrary.org/obo/NCIT_C96157) (Colorectal Large Cell Neuroendocrine Carcinoma), [NCIT:C115433](http://purl.obolibrary.org/obo/NCIT_C115433) (Recurrent Pancreatic Neuroendocrine Carcinoma), [NCIT:C95884](http://purl.obolibrary.org/obo/NCIT_C95884) (Gastric Neuroendocrine Carcinoma), [NCIT:C95620](http://purl.obolibrary.org/obo/NCIT_C95620) (Esophageal Large Cell Neuroendocrine Carcinoma), [NCIT:C43587](http://purl.obolibrary.org/obo/NCIT_C43587) (Colorectal Small Cell Neuroendocrine Carcinoma), [NCIT:C95583](http://purl.obolibrary.org/obo/NCIT_C95583) (Pancreatic Small Cell Neuroendocrine Carcinoma), [NCIT:C95582](http://purl.obolibrary.org/obo/NCIT_C95582) (Pancreatic Large Cell Neuroendocrine Carcinoma), [NCIT:C96919](http://purl.obolibrary.org/obo/NCIT_C96919) (Gallbladder Neuroendocrine Carcinoma), [NCIT:C126324](http://purl.obolibrary.org/obo/NCIT_C126324) (Gastroesophageal Junction Neuroendocrine Carcinoma), [NCIT:C126323](http://purl.obolibrary.org/obo/NCIT_C126323) (Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma), [NCIT:C95985](http://purl.obolibrary.org/obo/NCIT_C95985) (Ampulla of Vater Large Cell Neuroendocrine Carcinoma), [NCIT:C126325](http://purl.obolibrary.org/obo/NCIT_C126325) (Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma), [NCIT:C95984](http://purl.obolibrary.org/obo/NCIT_C95984) (Ampulla of Vater Neuroendocrine Carcinoma), [NCIT:C95885](http://purl.obolibrary.org/obo/NCIT_C95885) (Gastric Large Cell Neuroendocrine Carcinoma), [NCIT:C96956](http://purl.obolibrary.org/obo/NCIT_C96956) (Extrahepatic Bile Duct Neuroendocrine Carcinoma), [NCIT:C96958](http://purl.obolibrary.org/obo/NCIT_C96958) (Extrahepatic Bile Duct Large Cell Neuroendocrine Carcinoma), [NCIT:C96064](http://purl.obolibrary.org/obo/NCIT_C96064) (Small Intestinal Neuroendocrine Carcinoma), [NCIT:C96065](http://purl.obolibrary.org/obo/NCIT_C96065) (Small Intestinal Large Cell Neuroendocrine Carcinoma), [NCIT:C6764](http://purl.obolibrary.org/obo/NCIT_C6764) (Gastric Small Cell Neuroendocrine Carcinoma), [NCIT:C6761](http://purl.obolibrary.org/obo/NCIT_C6761) (Colon Small Cell Neuroendocrine Carcinoma), [NCIT:C3770](http://purl.obolibrary.org/obo/NCIT_C3770) (Pancreatic Neuroendocrine Carcinoma), [NCIT:C6763](http://purl.obolibrary.org/obo/NCIT_C6763) (Gallbladder Small Cell Neuroendocrine Carcinoma), [NCIT:C6762](http://purl.obolibrary.org/obo/NCIT_C6762) (Esophageal Small Cell Neuroendocrine Carcinoma), [NCIT:C43555](http://purl.obolibrary.org/obo/NCIT_C43555) (Appendix Small Cell Neuroendocrine Carcinoma), [NCIT:C27449](http://purl.obolibrary.org/obo/NCIT_C27449) (Small Intestinal Small Cell Neuroendocrine Carcinoma), [NCIT:C96063](http://purl.obolibrary.org/obo/NCIT_C96063) (Intestinal Neuroendocrine Carcinoma), [NCIT:C96787](http://purl.obolibrary.org/obo/NCIT_C96787) (Liver Neuroendocrine Carcinoma), [NCIT:C96425](http://purl.obolibrary.org/obo/NCIT_C96425) (Appendix Neuroendocrine Carcinoma), [NCIT:C96921](http://purl.obolibrary.org/obo/NCIT_C96921) (Gallbladder Large Cell Neuroendocrine Carcinoma), [NCIT:C96426](http://purl.obolibrary.org/obo/NCIT_C96426) (Appendix Large Cell Neuroendocrine Carcinoma), [NCIT:C96549](http://purl.obolibrary.org/obo/NCIT_C96549) (Anal Canal Neuroendocrine Carcinoma), [NCIT:C95619](http://purl.obolibrary.org/obo/NCIT_C95619) (Esophageal Neuroendocrine Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.92%
- [NCIT:C28079](http://purl.obolibrary.org/obo/NCIT_C28079) (Grade 3) 52.08%
- [NCIT:C14158](http://purl.obolibrary.org/obo/NCIT_C14158) (High Grade) 52.08%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C14161](http://purl.obolibrary.org/obo/NCIT_C14161) (Low Grade))) 52.08%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) 37.44%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma))) 37.44%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma))) 37.44%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma))) 37.44%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C40146](http://purl.obolibrary.org/obo/NCIT_C40146) (Grade 1 Endometrial Endometrioid Adenocarcinoma))) 37.44%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C40142](http://purl.obolibrary.org/obo/NCIT_C40142) (Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease))) 37.44%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C40141](http://purl.obolibrary.org/obo/NCIT_C40141) (Wolffian Adnexal Tumor))) 37.44%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C40139](http://purl.obolibrary.org/obo/NCIT_C40139) (Uterine Ligament Clear Cell Adenocarcinoma))) 37.44%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C40138](http://purl.obolibrary.org/obo/NCIT_C40138) (Uterine Ligament Endometrioid Adenocarcinoma))) 37.44%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C40137](http://purl.obolibrary.org/obo/NCIT_C40137) (Uterine Ligament Mucinous Adenocarcinoma))) 37.44%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C40129](http://purl.obolibrary.org/obo/NCIT_C40129) (Fallopian Tube Adenomatoid Tumor))) 37.44%


